Dicerna Pharmaceuticals Inc. (DRNA) Rose 5.27% or 0.53 To Price $10.58 On Thursday


Dicerna Pharmaceuticals Inc. (DRNA) rose 5.27% or 0.53 to $10.58. It is close to 169010 shares traded, which is 26.81% compare to the average total volume 630500. The market cap of DRNA is $663.70 million. The year to date change is -9.34%. The 52 week price range is from $8.71 to $17.98. Price of DRNA have changed -2.05% during last week. It have changed -5.99% over last month, -26.21% over last 3 months, -19.21% over last 6 months and 1.72% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 12.01. It is 13.52% above current price. The 200-day Moving Averages for DRNA is 13.31. It is 25.80% above current price. The 52-week High is 17.98. It is 69.94% from the current price. The 52-week Low is 8.71. It is -17.67% from current price.

There are some statistics of DRNA. It is has market cap $663.70 million. The share outstanding is 62.73 million. The average volume is 630500. The percent of top 15 Institution holding is 106.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -121.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -69.60%.


Tags:

Share this post